Eran Elizur’s Post

At Quantiphi, we're leveraging technologies like generative AI and digital twins to reshape healthcare and life sciences. We're speeding up drug discovery with AI-generated molecules, cutting down on animal testing with DART, and enhancing drug safety monitoring. Our AI-first approach empowers organizations to innovate responsibly and deliver better outcomes. #Quantiphi #SolvingWhatMatters #HealthcareInnovation #DigitalTransformation #GenerativeAI #LifeSciences

Imagine being able to predict molecular interactions and optimize drug candidates before even stepping into a lab. Quantiphi’s AI-driven molecular docking and simulation studies are making that possible, transforming how we conduct life sciences research. This generative chemistry approach allows us to create novel molecules with higher accuracy and speed, opening new doors in drug development.

It was great pleasure to attend an expert panel at #GTC24 and explore the transformative impact of #GenerativeAI on patient care, research, and #healthcare economics. Led by Kimberly Powell, Eric Topol, MD, Catherine Wood, and Dr. Peter Lee. They shared their perspective how generative AI is going to empower precision medicine, #disrupt and open healthcare to become one of the largest tech industry. Interesting part of discussion was about biggest challenges, over promises and #threats from incorporating precision genomics and multi-OMICS into medical practice. 🟢Gaps in data, whole genome sequencing processes must be completed, data from different ethnic groups should be incorporated into control reference genomes 🟢Limited understanding. Huge numbers of data are being generated and collected but there is no translation it into clinical practice 🟢Too fast implementation of AI solutions into diagnostics raised concerns about the safety and potential risks 🟢Lack of clear data #governance, clear regulation are needed avoid commercial exploitation of one of people's most personal assets 🟢Fear from the #change 🟢Lack of digitization of the healthcare system 🟢#Financial markets and investors are still resistant and concerned about multi omics initiatives, that could lead to over promised empty balloon hype and create losses Session ended with physiological reflection about “Gift of time” and believed that merging generative AI algorithms with multi omics data finally makes a change and speed up the development. #generativeai #AI #biopharmaceutical #medicaldevice #genomics #medicalimaging #roboticsurgery #medtech #gtc24 #gtc #nvidia #wholegenomesequencing #transcriptomics #singlecell #spacialcomputing #spacialbiology

🌟 When you're on a mission to make healthcare affordable and accessible using cutting-edge technologies like data analytics and AI, it's essential to look up to pioneers like Insilico Medicine. Their groundbreaking work has opened a new paradigm in drug discovery, showcasing the power of AI to accelerate and reduce the cost of bringing new treatments to market. I had the incredible opportunity to meet Alex Zhavoronkov, the visionary behind Insilico Medicine. His insights into AI-driven drug discovery and development were truly inspiring. Insilico's achievements, such as advancing their first AI-designed drug to Phase II clinical trials, demonstrate the transformative potential of AI in healthcare. 🚀 #HealthcareInnovation #AI #DataAnalytics #AffordableHealthcare #InsilicoMedicine #AQBSolutions #Innovation

Exciting news in the world of drug discovery! NVIDIA has unveiled BioNeMo, a generative AI platform capable of analyzing DNA sequences, predicting protein shapes, and determining cell functions based on RNA. With the ability to simplify and accelerate model training on proprietary data, BioNeMo has the potential to transform how we approach disease treatment. From personalized medicine to drug optimization, this platform is poised to make a significant impact on the industry. By democratizing AI-driven drug discovery, BioNeMo empowers researchers worldwide to make breakthroughs that benefit patients and society as a whole. Learn more about this groundbreaking technology and its potential to revolutionize the field. #drugdiscovery #AI #BioNeMo #innovation

Two AI giants Alán Aspuru-Guzik and Alex Zhavoronkov meet in one room! Alex Zhavoronkov is currently presenting at the Acceleration Consortium seminar at the University of Toronto. Don’t miss this opportunity to hear about the latest advancements in #drug development using #AI technologies at Insilico Medicine! Happening now: https://lnkd.in/gU6F_5fG #drug #discovery #AI #ML #aging #acceleration #science #insilico

At the ERS 2024 the role of AI both in imaging modalities and in drug discovery took prominent role. For example, in the chart we can clearly see growing number of molecules are entering trials with the help of AI. It suggests that AI continues to refine drug discovery and the pipeline for new drugs is expanding. If AI continues to improve trial success rates or optimize participant selection, we might see an increase in the percentage of successful launches over time. #ERS2024 #DrugDiscovery #ClinicalTrials #HealthTech

Hello, drug discovery professionals! Explore Episode #3 of our webinar series: "Generative AI-based Platform for Augmented Molecule Design and Property Evaluation." In this episode, we delve into the capabilities of our AI-driven platform, ID4Idea, showcasing how it enhances compound chemical space through de novo design, active learning-driven virtual screening, and accurate ADMET predictions via AI-based modeling. Register now to access the video and gain valuable insights!

As part of our #XscaleInsights series, Anjani Bansal from Global Brain Corporation delivered a thought-provoking insight during Coffee with Xscale 2.0: "The future of healthcare lies in AI, especially in personal medicine and drug discovery." Anjani shared how AI has the power to dramatically transform drug development, cutting the timeline for new drugs—from the current 10 years for clinical trials—to a fraction of that. Imagine the impact: faster treatments, personalized medicine, and a revolution in healthcare innovation. The opportunities are limitless as AI reshapes the way we discover life-saving drugs. Catch more groundbreaking insights from this conversation on YouTube! #XscaleInsights #HealthcareRevolution #AIinMedicine ##GlobalBrain #InnovationInHealthcare #CoffeeWithXscale Neeraj Saxena Anshul Saxena Amit Sharma Addison Appu Rajat Tandon

Areti Founders Ilya Gluhovsky and Paul Neyman are at Global Bio Conference 2024. Connect with us to accelerate your clinical trial recruitment, boost your conversions and cut costs with our AI Coordinator. #bio2024 #ai #generativeai